{"id":17709,"date":"2015-04-06T07:07:58","date_gmt":"2015-04-06T11:07:58","guid":{"rendered":"http:\/\/therapytoronto.ca\/news\/?p=17709"},"modified":"2015-04-06T23:29:50","modified_gmt":"2015-04-07T03:29:50","slug":"common-antidepressant-increased-coronary-atherosclerosis-in-animal-model","status":"publish","type":"post","link":"https:\/\/therapytoronto.ca\/news\/2015\/04\/common-antidepressant-increased-coronary-atherosclerosis-in-animal-model\/","title":{"rendered":"Common antidepressant increased coronary atherosclerosis in animal model"},"content":{"rendered":"<p>From the Wake Forest Baptist Medical Center media release:<\/p>\n<blockquote><p><strong><img loading=\"lazy\" class=\"alignright size-full wp-image-9629\" src=\"http:\/\/therapytoronto.ca\/news\/wp-content\/uploads\/2013\/01\/vitamins_pills.jpg\" alt=\"drugs\" width=\"300\" height=\"199\" \/>A commonly prescribed antidepressant caused up to a six-fold increase in atherosclerosis plaque in the coronary arteries of non-human primates<\/strong>, according to a study by researchers at Wake Forest Baptist Medical Center. Coronary artery atherosclerosis is the primary cause of heart attacks.<\/p>\n<p>The study is published in the current online issue of the journal <i>Psychosomatic Medicine<\/i>.<\/p>\n<p>&#8220;<strong>The medical community has known for years that depression is closely associated with heart disease<\/strong>, but we didn&#8217;t know if treating it would reduce the heart disease risk,&#8221; said Carol Shively, Ph.D., professor of pathology\/comparative medicine at Wake Forest Baptist and lead author of the study.<\/p>\n<p>In the study, 42 middle-aged female monkeys were fed a Western-like diet containing fat and cholesterol for 18 months. During this pre-treatment phase, depressive behavior in the animals was recorded.<\/p>\n<p>Female animals were chosen for the study because coronary heart disease is the leading cause of death in women in the United States, and <strong>depressive disorders are twice as likely in women as in men<\/strong>.<\/p>\n<p>The animals were then randomly assigned to receive a commonly prescribed antidepressant, a selective serotonin reuptake inhibitor (SSRI) marketed under the brand name Zoloft, or a placebo once a day for 18 months. The antidepressant was given in a dose comparable to that given to patients.<\/p>\n<p><strong>The monkeys that received the SSRI developed three times the amount of atherosclerosis in their coronary arteries as monkeys given the placebo<\/strong>. In the depressed animals, the amount was even higher &#8211; almost six times greater in the SSRI-treated animals than in those given the placebo.<\/p>\n<p>&#8220;Our findings suggest that <strong>long-term treatment with this drug promotes coronary artery atherosclerosis in non-human primates<\/strong>,&#8221; Shively said. &#8220;This may be clinically significant for people because almost a quarter of middle-aged women in the United States take antidepressants, the most prescribed of which are SSRIs.&#8221;<\/p>\n<p>Shively added that although more research is needed, doctors may want to keep these findings in mind when they are prescribing antidepressants. <strong>Previous studies have shown that exercise and counseling may be as effective as SSRIs in treating depression for many people<\/strong>.<\/p><\/blockquote>\n<p>The study was funded by the National Institutes of Health grant RO1HL087103.<\/p>\n<p>Co-authors of the study are Thomas C. Register, Ph.D., Susan E. Appt, D.V.M., and Thomas B. Clarkson, D.V.M. of Wake Forest Baptist.<\/p>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>From the Wake Forest Baptist Medical Center media release: A commonly prescribed antidepressant caused up to a six-fold increase in atherosclerosis plaque in the coronary arteries of non-human primates, according&#8230; <a class=\"read-more-link\" href=\"https:\/\/therapytoronto.ca\/news\/2015\/04\/common-antidepressant-increased-coronary-atherosclerosis-in-animal-model\/\">Read more &raquo;<\/a><!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[345,10,358],"tags":[],"_links":{"self":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/17709"}],"collection":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/comments?post=17709"}],"version-history":[{"count":1,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/17709\/revisions"}],"predecessor-version":[{"id":17710,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/17709\/revisions\/17710"}],"wp:attachment":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/media?parent=17709"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/categories?post=17709"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/tags?post=17709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}